Additionally, the combination of HPNS and probiotics reduced serum levels of inflammatory cytokines (TNF-a, IL-1, IL-6), which are commonly elevated in critically ill patients and contribute to developing infections like VAP By regulating the inflammatory response, this intervention may help reduce the risk of infection and promote faster recovery. The gene discussed is IL6; the disease is ventilator-associated pneumonia.